Monday , October 23 2017
Home / Letter From The Editor / GLP-1 Agonists Special Edition, February 2014

GLP-1 Agonists Special Edition, February 2014

When we talk to diabetes experts they all say that GLP-1 agonists will continue to change the way we treat diabetes now and in the future. They also comment on the slow but growing acceptance of this class as the "go to" drug for type 2 diabetes.

In last month’s Special Edition, we looked at possible defects in GLP-1 production, degradation and clearance in diabetes patients. This month, we turn our attention to mechanisms that control GLP-1 release and how certain medications, nutritional products, and surgeries can change this release